Etomidate Injection

11 November 2009

Products Affected - Description

Etomidate 2 mg/mL injection, Bedford
10 mL vial (NDC 55390-0762-10)
20 mL vial (NDC 55390-0763-20)

Reason for the Shortage

Bedford states etomidate injection is in short supply due to increased demand for product.

Estimated Resupply Dates

• Bedford cannot provide an estimated resupply date for their etomidate products.
• Hospira has available Amidate 10 mL ampules (NDC 00409-8062-01), 10 mL vials (NDC 00409-6695-01), 20 mL ampules (NDC 00409-8061-01), 20 mL vials (NDC 00409-6695-02) and 20 mL Lifeshield systems (NDC 00409-8060-29) in limited supply.

Safety

Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Related Shortages

• Hydroxyzine Injection, Tablets, Capsules, and Syrup— Resolved
• Lorazepam
• Meprobamate Oral Tablet— Resolved
• Secobarbital Capsules— Resolved
• Zaleplon Capsules— Resolved

Updated

November 11, 2009; September 16, 2009; July 30, 2009; June 16, 2009; May 11, 2009; April 6, 2009; February 27, 2009; February 23, 2009; February 10, 2009; January 6, 2009; December 10, 2008; November 14, 2008; October 15, 2008; September 2, 2008; August 7, 2008; July 30, 2008; July 22, 2008; July 10, 2008; June 16, 2008, University of Utah, Drug Information Service. Copyright 2009, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins